New Jersey-based manufacturers Johnson & Johnson have once again come under the scrutiny of the Food and Drug Administration (FDA), this time for defective insulin pumps made by their Animas Corp. unit. However, the product defects are not the only problems to come to light. The FDA has also found that J&J delayed reporting two cases of injury due to the insulin pumps and never reported another, according to the Associated Press.
The three injuries left patients hospitalized for dangerously high blood
sugar which resulted in respiratory failure and coma as their insulin
pumps had failed to inject them with insulin in order to protect them
from the effects of their diabetes while they ate. When a person suffers
from diabetes, they lack the proper amount of insulin, which helps break
down the sugars in their bloodstream and protects them from adverse effects.
As such, medications such as insulin pumps help keep diabetic patients
from building up too much blood sugar and being injured.
When a consumer is injured by a product, manufacturers are required to report the incident to the FDA within 30 days. J&J claimed that the injuries resulted from user error; however, the FDA is currently investigating the reasons behind the failure to report. In addition, the FDA is investigating J&J’s Animas Corp. for inadequately responding to the agency’s August inspection, which found problems with the keypads featured on some of the company’s insulin pumps.
Johnson and Johnson has come under great scrutiny in the past year for several recalled products, such as hip replacements, and a campaign against toxic chemicals in baby products.
Manufacturers are not only morally obligated to create safe products in the U.S., but are legally required to make sure their products do not harm consumers. A San Jose dangerous product injury lawyer at Caputo & Van Der Walde LLP can help you win the compensation you deserve for you losses. Call us today at (800) 900-0863.